Hitachi Software Engineering America Ltd. and OriGene Technologies Inc. announced a comarketing agreement to jointly promote OriGene’s multiplex assays built on Luminex xMAP/Bio-Plex technology and Hitachi Software’s MasterPlex software suite for analysis and reporting of multiplex assay data. According to the agreement, OriGene will use MasterPlex exclusively in all immunoassay and custom assay development. Customers purchasing OriGene’s assays will be offered the use of MasterPlex software product for 30 days. The agreement will also enable Hitachi Software’s clients to have easy access to information and preferred purchasing arrangements for OriGene’s broad range of assays.

The Hitachi Software MasterPlex Suite delivers a combination of analysis, quality control, and reporting tools for data sets in both research and 21 CFR Part 11-compliant labs. MasterPlex is hardware independent and offers a variety of features not commonly found in a single analysis application. MasterPlex has been developed over the past eight years and is currently being used by laboratories in universities, institutions, and companies in the life sciences industry in more than 20 countries.

OriGene’s strength in multiplexed assays relies on its genome wide collection of full-length human cDNA clones, more than 5000 human-cell produced proteins, and its growing collection of TrueMAB monoclonal antibodies. OriGene scientists have developed many research and diagnostic assays based on Luminex platform, including multiplexed assays for microRNA expression, transcription factors profiling, and genotyping.